GENSCO

What this means for you

Registered since 14 Mar 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal is due by 14 Mar 2027, and its filing window is open now).

Record

Serial number

87129073

Registration number

5160780

Mark type

Word mark

Filed

05 Aug 2016

Published for opposition

27 Dec 2016

Registered

14 Mar 2017

Next maintenance filing

§8 & §9 renewal, due by 14 Mar 2027 (grace period to 14 Sept 2027)

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for topical gels and ointments for transdermal delivery of analgesics, anti-inflammatory agents, antineoplastic agents, muscle relaxants, anaesthetic agents, peptides, proteins, growth factors, hormones, substance P antagonists, antifungal compounds, antiviral compounds, antibacterial compounds, antiobesity drugs, homeopathic agents, antianginal compounds, hair growth stimulators or retardants, nutrients, and antimetabolite

Owner

• Gensco Laboratories, LLC, Doral, FL, US
• Gensco Laboratories, LLC, Doral, FL, US
• Gensco Laboratories, LLC, Doral, FL, US

Prosecution history

• 14 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 01 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 01 Sept 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 01 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 03 Mar 2023 — TEAS SECTION 8 & 15 RECEIVED
• 14 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 14 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
• 27 Dec 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 27 Dec 2016 — PUBLISHED FOR OPPOSITION
• 07 Dec 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 18 Nov 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 16 Nov 2016 — ASSIGNED TO EXAMINER
• 10 Aug 2016 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 09 Aug 2016 — NEW APPLICATION ENTERED